These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6263454)

  • 1. Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
    Valdivieso M; Tenczynski TF; Rodriguez V; Burgess MA; Mountain CF; Barkley HT; Hersh EM; Bodey GP
    Cancer; 1981 Jul; 48(2):238-44. PubMed ID: 6263454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
    Spitzer G; Farha P; Valdivieso M; Dicke K; Zander A; Vellekoop L; Murphy WK; Dhingra HM; Umsawasdi T; Chiuten D
    J Clin Oncol; 1986 Jan; 4(1):4-13. PubMed ID: 3510281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
    Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
    Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
    Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
    Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
    Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
    Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
    Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
    Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.
    Israël L; Depierre A; Choffel C; Milleron B; Edelstein R
    Cancer Treat Rep; 1977; 61(3):343-7. PubMed ID: 68827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Frankmann C; Murphy WK; Benjamin RS; Barkley HT; McMurtrey MJ; Jeffries DG; Welch SR; Bodey GP
    Cancer; 1987 Jan; 59(2):362-9. PubMed ID: 3026605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
    Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
    Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
    Evans WK; Osoba D; Feld R; Shepherd FA; Bazos MJ; DeBoer G
    J Clin Oncol; 1985 Jan; 3(1):65-71. PubMed ID: 2981293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.